AlternativeYentreve (SUI) / Cymbalta (depression)
Duloxetine
SNRI
Only licensed pharmacotherapy for stress urinary incontinence.
Oral
First-line for
- Moderate–severe stress urinary incontinence (adjunct to pelvic floor training)
- Depression / GAD / diabetic neuropathy
Mechanism
Serotonin + noradrenaline reuptake inhibition → central Onuf's nucleus stimulation → ↑ urethral sphincter tone.
"Duloxetine = Do pelvic floor first"
- Physio + duloxetine >> either alone
- Start low — nausea is the top drop-out reason
- Suicidal ideation warning in <25s
Dosing
- SUI start
- 20 mg BD × 2 weeks
- SUI maintain
- 40 mg BD
- Depression
- 60 mg OD; max 120 mg/day
Contraindications
- AbsoluteConcurrent MAOI
- AbsoluteSevere hepatic/renal impairment
- AbsoluteUncontrolled narrow-angle glaucoma
Side effects
- Nausea (50%)
- Dry mouth, constipation
- Insomnia, dizziness
- Hepatotoxicity, hypertension
- Discontinuation syndrome
Fetal & maternal notes
- • Limited data — avoid in pregnancy; if unavoidable, standard SSRI/SNRI cautions apply
Key interactions
MAOIs / tramadol / linezolid
AvoidSerotonin syndrome
CYP1A2 inhibitors (ciprofloxacin, fluvoxamine)
Caution↑ duloxetine levels
Clinical pearls
- 💡 Titrate slowly and take with food to survive the nausea window
- 💡 Assess at 3 months — if no benefit, stop and refer for surgical options
Content last reviewed: REPLACE_ME (e.g. 2026-07)
Spotted something out of date? See our disclaimer or use Report an Error above.